SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $32,000 | -85.7% | 1,360 | -88.9% | 0.00% | – |
| Q1 2020 | $224,000 | -28.2% | 12,260 | -6.7% | 0.00% | -100.0% |
| Q4 2019 | $312,000 | -65.1% | 13,141 | -14.4% | 0.00% | -50.0% |
| Q2 2018 | $895,000 | +28.0% | 15,343 | +0.5% | 0.00% | +100.0% |
| Q1 2018 | $699,000 | +28.7% | 15,267 | +12.1% | 0.00% | 0.0% |
| Q4 2017 | $543,000 | +63.1% | 13,624 | +61.0% | 0.00% | 0.0% |
| Q3 2017 | $333,000 | – | 8,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |